Prof. Dr. Maha Mohammed Jasim Al-Bayati, Dr. Noor Ghazi Saleh
Vol. 16, Issue 1, Jul-Dec 2023
Abstract:
Background: The prevalence of gestational diabetes mellitus has increased dramatically during the previous few decades. Neuregulin 4 is a new protein that protects against diet-induced insulin resistance and steatosis in the liver. Neuregulin 4 levels in subcutaneous and visceral adipose tissues were significantly lower in patients with impaired glucose tolerance or diabetes than in healthy people, according to a recent study. Aim: To evaluate the clinical significance of serum Neuregulin 4 and other metabolic parameters in gestational diabetes mellitus. Methods: A casecontrol study was conducted during the period from February to October 2021. The study included 90 pregnant women in the second trimester and was divided into two groups; the gestational diabetes mellitus group (included 45 women who presented with gestational diabetes during current pregnancy) and control group (included 45 healthy pregnant women matched for age, gestational age). Neuregulin 4 and other parameters were measured in the two groups.
DOI: http://doi.org/10.37648/ijrmst.v16i01.012
Disclaimer: Indexing of published papers is subject to the evaluation and acceptance criteria of the respective indexing agencies. While we strive to maintain high academic and editorial standards, International Journal of Research in Medical Sciences and Technology does not guarantee the indexing of any published paper. Acceptance and inclusion in indexing databases are determined by the quality, originality, and relevance of the paper, and are at the sole discretion of the indexing bodies.